https://www.selleckchem.com/pr....oducts/BafilomycinA1
Nineteen patients did not complete follow-up and it was not possible to identify the date of death in four others. Therefore, 110 patients were included in the analysis. At baseline, 81% presented ≥150 eosinophil cells and 72% presented ≥2%. We identified a three-fold higher risk of death in those with 2% eosinophils and 150 cells. We did not identify statistical differences when using other cutoff points. The decrease in number of peripheral eosinophils, with cutoff points at 2% and 150 cells, may be associated with a hig
Like
Comment
Share
